North America Veterinary API Market Size, Share & Industry Trends Analysis Report By Route of Administration, By API Type, By Synthesis Type, By Animal Type, By Country and Growth Forecast, 2023 - 2030

North America Veterinary API Market Size, Share & Industry Trends Analysis Report By Route of Administration, By API Type, By Synthesis Type, By Animal Type, By Country and Growth Forecast, 2023 - 2030


The North America Veterinary API Market would witness market growth of 5.7% CAGR during the forecast period (2023-2030).

The production of veterinary active pharmaceutical ingredients entails the synthesis of APIs from basic materials using various high-tech processing techniques. Anti-infectives, vaccines, and nonsteroidal anti-inflammatory drugs are the principal products of veterinary active pharmaceutical ingredient production. It is expected that an increasing number of pet owners will drive the development of the market in the coming years. Pet proprietors are those who own or adopt a companion animal. The fact that pet owners provide essential health care for their animals increases the demand for veterinary medications.

The launch of biologically synthesized APIs is an advancement in technology that contributes to the expansion of the industry. In the future, veterinary biopharmaceuticals produced by rDNA technology will be a more viable option for treating diseases such as arthritis, cancer, and diabetes, as well as autoimmune disorders. In addition, introducing high-potency APIs (HPAPIs), which act on target cells at a much lower dosage than standard APIs, is anticipated to create lucrative possibilities for expansion in the market. The HPAPIs are causing significant alterations in the pharmaceutical industry's ability to develop novel therapeutic drugs.

In March 2022, Mainstreet Animal Hospital in Canada published an article on Primary Veterinary Care that discussed the numerous pet-related complications and their management. According to the article, old age significantly contributes to the advent of chronic diseases like osteoarthritis, heart disease, renal disease, endocrinological disorders, etc. The increasing prevalence of chronic diseases in veterinary animals and the need for appropriate medical management, such as the provision of effective medications for afflicted animals, are likely to drive market expansion in the region. Consequently, all of the factors above, such as the rise in pet ownership and the prevalence of chronic diseases in animals, are anticipated to bolster the regional market over the forecast period.

The US market dominated the North America Veterinary API Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $3,286.9 million by 2030. The Canada market is experiencing a CAGR of 8.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 7.1% during (2023 - 2030).

Based on Route of Administration, the market is segmented into Oral, Injectable, Topical and Others. Based on API Type, the market is segmented into Parasiticides, Anti-inflammatory, Antimicrobials, Vaccines, Hormones and Others. Based on Synthesis Type, the market is segmented into Chemical based API, Biological API and Highly potent API. Based on Animal Type, the market is segmented into Livestock Animals and Companion Animals. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Zoetis, Inc., Elanco Animal Health, Inc., Merck & Co., Inc., Virbac, Vetoquinol SA (Soparfin SCA), Sequent Scientific Limited, Phibro Animal Health Corporation, Febbrica Italina Sintetici S.P.A. (Nine Trees Group S.p.A) and Excel Industries Limited.

Scope of the Study

Market Segments covered in the Report:

By Route of Administration
  • Oral
  • Injectable
  • Topical
  • Others
By API Type
  • Parasiticides
  • Anti-inflammatory
  • Antimicrobials
  • Vaccines
  • Hormones
  • Others
By Synthesis Type
  • Chemical based API
  • Biological API
  • Highly potent API
By Animal Type
  • Livestock Animals
  • Companion Animals
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Boehringer Ingelheim International GmbH
  • Zoetis, Inc.
  • Elanco Animal Health, Inc.
  • Merck & Co., Inc.
  • Virbac
  • Vetoquinol SA (Soparfin SCA)
  • Sequent Scientific Limited
  • Phibro Animal Health Corporation
  • Febbrica Italina Sintetici S.P.A. (Nine Trees Group S.p.A)
  • Excel Industries Limited
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Veterinary API Market, by Route of Administration
1.4.2 North America Veterinary API Market, by API Type
1.4.3 North America Veterinary API Market, by Synthesis Type
1.4.4 North America Veterinary API Market, by Animal Type
1.4.5 North America Veterinary API Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. Strategies Deployed in Veterinary API Market
Chapter 5. North America Veterinary API Market by Route of Administration
5.1 North America Oral Market by Country
5.2 North America Injectable Market by Country
5.3 North America Topical Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Veterinary API Market by API Type
6.1 North America Parasiticides Market by Country
6.2 North America Anti-inflammatory Market by Country
6.3 North America Antimicrobials Market by Country
6.4 North America Vaccines Market by Country
6.5 North America Hormones Market by Country
6.6 North America Others Market by Country
Chapter 7. North America Veterinary API Market by Synthesis Type
7.1 North America Chemical based API Market by Country
7.2 North America Biological API Market by Country
7.3 North America Highly potent API Market by Country
Chapter 8. North America Veterinary API Market by Animal Type
8.1 North America Livestock Animals Market by Country
8.2 North America Companion Animals Market by Country
Chapter 9. North America Veterinary API Market by Country
9.1 US Veterinary API Market
9.1.1 US Veterinary API Market by Route of Administration
9.1.2 US Veterinary API Market by API Type
9.1.3 US Veterinary API Market by Synthesis Type
9.1.4 US Veterinary API Market by Animal Type
9.2 Canada Veterinary API Market
9.2.1 Canada Veterinary API Market by Route of Administration
9.2.2 Canada Veterinary API Market by API Type
9.2.3 Canada Veterinary API Market by Synthesis Type
9.2.4 Canada Veterinary API Market by Animal Type
9.3 Mexico Veterinary API Market
9.3.1 Mexico Veterinary API Market by Route of Administration
9.3.2 Mexico Veterinary API Market by API Type
9.3.3 Mexico Veterinary API Market by Synthesis Type
9.3.4 Mexico Veterinary API Market by Animal Type
9.4 Rest of North America Veterinary API Market
9.4.1 Rest of North America Veterinary API Market by Route of Administration
9.4.2 Rest of North America Veterinary API Market by API Type
9.4.3 Rest of North America Veterinary API Market by Synthesis Type
9.4.4 Rest of North America Veterinary API Market by Animal Type
Chapter 10. Company Profiles
10.1 Boehringer Ingelheim International Gmbh
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional & Segmental Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.5.2 Partnerships, Collaborations and Agreements:
10.1.6 SWOT Analysis
10.2 Zoetis, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Product Launches and Product Expansions:
10.2.5.2 Approvals and Trials:
10.2.5.3 Acquisition and Mergers:
10.2.6 SWOT Analysis
10.3 Elanco Animal Health, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Acquisition and Mergers:
10.3.6 SWOT Analysis
10.4 Merck & Co., Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent strategies and developments:
10.4.5.1 Geographical Expansions:
10.4.6 SWOT Analysis
10.5 Virbac
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Recent strategies and developments:
10.5.4.1 Product Launches and Product Expansions:
10.5.5 SWOT Analysis
10.6 Vetoquinol SA (Soparfin SCA)
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 SWOT Analysis
10.7 Sequent Scientific Limited
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 SWOT Analysis
10.8 Phibro Animal Health Corporation
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 SWOT Analysis
10.9 Febbrica Italina Sintetici S.P.A. (Nine Trees Group S.p.A)
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Regional Analysis
10.10. Excel Industries Limited
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental Analysis
10.10.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings